The role for N-acetylcysteine in the management of COPD
International Journal of COPD · 2006
DOI: 10.2147/copd.2006.1.2.99 ↗At a glance
Übersichtsarbeit in International Journal of COPD, 2006. Written by P N R Dekhuijzen and 1 co-authors. Institution: Department of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, The Netherlands. r.dekhuijzen@long.umcn.nl. Cited 14 times so far (Crossref); 68 references. The full text is freely available in PubMed Central.
Topics: COPD
Abstract (original language)
Oxidative stress has been implicated in the pathogenesis and progression of COPD. Both reactive oxidant species from inhaled cigarette smoke and those endogenously formed by inflammatory cells constitute an increased intrapulmonary oxidant burden. Structural changes to essential components of the lung are caused by oxidative stress, contributing to irreversible damage of both parenchyma and airway walls. The antioxidant N-acetylcysteine (NAC), a glutathione precursor, has been applied in these patients to reduce symptoms, exacerbations, and the accelerated lung function decline. This article reviews the available experimental and clinical data on the antioxidative effects of NAC in COPD, with emphasis on the role of exhaled biomarkers.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, The Netherlands. r.dekhuijzen@long.umcn.nl
Cite
APA
Dekhuijzen, P. N., & van Beurden, W. J. (2006). The role for N-acetylcysteine in the management of COPD. International Journal of COPD. https://doi.org/10.2147/copd.2006.1.2.99
Vancouver
Dekhuijzen PN, van Beurden WJ. The role for N-acetylcysteine in the management of COPD. International Journal of COPD. 2006. doi:10.2147/copd.2006.1.2.99
BibTeX
@article{Dekhuijzen2006,
author = {Dekhuijzen, P N R and van Beurden, W J C},
title = {The role for N-acetylcysteine in the management of COPD},
journal = {International Journal of COPD},
year = {2006},
doi = {10.2147/copd.2006.1.2.99}
}
EUVIMED